Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Sofosbuvir delayed by NHS England due to high cost


Guru

Status: Offline
Posts: 5629
Date:
Sofosbuvir delayed by NHS England due to high cost
Permalink  
 


Yes it`s very disappointing news, Nirmalee, particularly as NICE were all prepared to back Sovaldi as being a cost effective treatment.  It seems very short-sighted but lets hope it is actually a delay rather than a refusal, and hopefully the NHS will allow it later this year.

Your consultant seems very on the ball and that must have been a huge help to you and very reassuring.

Thanks for your comment. ~ Jill

 



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 



Senior Member

Status: Offline
Posts: 395
Date:
Permalink  
 

This is so disappointing Jill, my consultant warned me that this was going to happen.  That is why when I was at my lowest I begged them not to take me off the meds. When I did my 2nd bout of Interferon I had to fight with NICE for retreatment as the policy in my area was not to do it but now they are actively behind Solvadi which means they know it works.  For all those still waiting I hope these are approved soon.



__________________


Guru

Status: Offline
Posts: 5629
Date:
Permalink  
 

The NHS (National Health Serive) in England has taken the decision to delay the use of sofosbuvir because of the hight cost.

The move by NHS England is unprecedented, because the NHS rationing body, Nice (the National Institute for Health and Care Excellence) has approved the drug.  Nice says sofosbuvir is cost-effective, because it is a cure for people who would otherwise run up huge NHS bills.

Charles Gore, chief executive of the Hepatitis C Trust, said he was very concerned about the delay.  Nice had allowed NHS England to make a decision based on affordability rather than cost-effectiveness. "It feels to me as if a whole new criterion has been invented by the backdoor," he said.  If the NHS could delay using a new drug by four months, it could also delay by six months or a year -  or it could decide on the basis of its cash-strapped budget to use it one year but not the next.

Full article from the Hep C Tust (source - the Guardian newspaper)

http://www.hepctrust.org.uk/hepatitis-c-drug-sofosbuvir-delayed-nhs-due-high-cost

 

 

 



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.